NS · Healthcare

Acutaas Chemicals Ltd (ACUTAAS)

Pharmaceuticals & Biotechnology

Acutaas Chemicals Ltd (ACUTAAS) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $269.36B, P/E ratio is 73.55, net margin is 16.3%, dividend yield is 0.05%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ACUTAAS

Market cap

$269.36B

P/E ratio

73.55

Net margin

16.3%

Dividend yield

0.05%

Acutaas Chemicals Ltd (ACUTAAS) — FAQ

What is Acutaas Chemicals Ltd's market cap?

Acutaas Chemicals Ltd (ACUTAAS) has a reported market cap of $269.36B (data as of 2026-07-10).

What is ACUTAAS's P/E ratio?

The price-to-earnings (P/E) ratio for Acutaas Chemicals Ltd (ACUTAAS) is 73.55 (data as of 2026-07-10).

Does Acutaas Chemicals Ltd pay a dividend?

Acutaas Chemicals Ltd (ACUTAAS) shows a reported dividend yield of 0.05%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Acutaas Chemicals Ltd in?

Acutaas Chemicals Ltd (ACUTAAS) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is ACUTAAS listed on?

ACUTAAS is listed on NS.

What is Acutaas Chemicals Ltd's net margin?

Acutaas Chemicals Ltd (ACUTAAS) reports a net margin of 16.3% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)